Home › Juvenile Myelomonocytic Leukemia › Massachusetts › Boston
Juvenile Myelomonocytic Leukemia clinical trials in Boston, MA
3 studies for Juvenile Myelomonocytic Leukemia are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
RecruitingPhase 1
- Dana-Farber Cancer Institute, Boston
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecruitingPhase 1/2
- Dana-Farber Cancer Institute, Boston
A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
RecruitingPhase 1
- Boston Children's Hospital, Boston
- Dana Farber Cancer Institute, Boston
Juvenile Myelomonocytic Leukemia trials in other cities
- Philadelphia, PA4 studies
- Minneapolis, MN4 studies
- Seattle, WA3 studies
- Cincinnati, OH3 studies
- Chicago, IL3 studies
- Washington, DC3 studies
- Atlanta, GA3 studies
- New York City, NY3 studies
- Indianapolis, IN3 studies
- San Francisco, CA3 studies
- Ann Arbor, MI3 studies
- Memphis, TN3 studies
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.